All Sauce from Weekly Sauce:

The U.S. Food and Drug Administration on Friday gave the nod to a Florida plan to import drugs from Canada at much lower prices than in the United States. The approval could prove to be a major turning point for the United States’ prescription drug market. U.S. residents can now buy directly from Canadian pharmacies…  read on >  read on >

Combining mindfulness with exercise could be the key to managing stress during a potentially turbulent 2024, a new review argues. People who exercise and practice mindfulness meditation together tend to have less worry, stress, anxiety and depression than those who only engage in either activity, according to results from 35 studies involving more than 2,200…  read on >  read on >

Tejocote weight-loss supplements sold through online through Amazon or Etsy could contain a highly toxic substance, the U.S. Food and Drug Administration is warning. FDA tests revealed that capsules labeled as tejocote instead contained yellow oleander, a poisonous plant native to Mexico and Central America. The FDA found yellow oleander in nine different products labeled…  read on >  read on >

Teenagers who’ve packed on extra pounds have a significantly increased risk of developing kidney disease as a young adult, a new study finds. Obesity increased risk of later kidney disease as much as ninefold in boys and fourfold in girls, according to results published recently in the journal JAMA Pediatrics. Even a few extra pounds…  read on >  read on >

Migraines are not only extremely painful, but they also appear to pose a driving risk for seniors, a new study warns. Older adult drivers recently diagnosed with migraines are three times more likely to be involved in a car crash, researchers reported recently in the Journal of the American Geriatrics Society. “Migraine headaches affect more…  read on >  read on >

Drugs already used by millions to lower cholesterol might someday have a new role: Relieving asthma and COPD. That’s the hope of a new line of research underway at the University of California, Davis. A study funded by the U.S. National Institutes of Health is seeking to determine whether a “statin inhaler” might reduce the…  read on >  read on >